Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVSEF) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for Novartis Ag (NVSEF) over the last 17 years, with Q4 2025 value amounting to $2.3 billion.

  • Novartis Ag's Long-Term Investments rose 1652.61% to $2.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.3 billion, marking a year-over-year increase of 1652.61%. This contributed to the annual value of $2.3 billion for FY2025, which is 1652.61% up from last year.
  • According to the latest figures from Q4 2025, Novartis Ag's Long-Term Investments is $2.3 billion, which was up 1652.61% from $2.1 billion recorded in Q3 2025.
  • Novartis Ag's Long-Term Investments' 5-year high stood at $9.3 billion during Q3 2021, with a 5-year trough of $46.0 million in Q1 2023.
  • For the 5-year period, Novartis Ag's Long-Term Investments averaged around $3.2 billion, with its median value being $2.3 billion (2022).
  • As far as peak fluctuations go, Novartis Ag's Long-Term Investments crashed by 9830.32% in 2023, and later skyrocketed by 530652.17% in 2024.
  • Over the past 5 years, Novartis Ag's Long-Term Investments (Quarter) stood at $3.0 billion in 2021, then decreased by 20.59% to $2.4 billion in 2022, then rose by 8.13% to $2.6 billion in 2023, then decreased by 22.71% to $2.0 billion in 2024, then grew by 16.53% to $2.3 billion in 2025.
  • Its Long-Term Investments stands at $2.3 billion for Q4 2025, versus $2.1 billion for Q3 2025 and $2.1 billion for Q2 2025.